Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 37.57 | 41.60 |
| PEG Ratio (TTM) | 4.88 | 6.56 |
| P/S Ratio (TTM) | 3.06 | 4.12 |
| P/B Ratio (TTM) | 3.88 | 4.10 |
| P/FCF Ratio (TTM) | -4,328.33 | 31.45 |
| Price to 5YR AVG Earnings Ratio | 46.58 | 70.39 |
| Price to 5YR AVG FCF Ratio | 53.48 | 45.08 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.30% | 3.90% |
| ROE (TTM) | 10.69% | 14.91% |
| Net Profit Margin (TTM) | 8.14% | 10.66% |
| ROIC 5YR AVG | 12.67% | 13.31% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 243.45% | 232.43% | 149.86% |
| Revenue | 11.68% | 14.79% | 12.62% |
| Net Income | 243.74% | 237.81% | 153.02% |
| Cash Flow | -2.79% | 1,075.99% | 634.59% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.87 | 2.16 |
| Quick Ratio (TTM) | 2.05 | 1.45 |
| D/E Ratio (TTM) | 0.04 | 0.55 |
| Interest Coverage (TTM) | 10.70 | 8.43 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 7.87 | 5.16 |
| LTL to 5YR AVG FCF | N/A | 5.03 |
| Shares Outstanding Growth 5YR AVG | 0.83% | 5.28% |